In contrast, O-1602 (a GPR55 agonist) showed a protective effect against experimentally induced colitis, reducing inflammation and inhibiting neutrophil migration even in CB1/CB2 and GPR55 knockout mice (29). This evidence concerns the gene CNR1 and colitis.